Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Theresa R. Fletcher is active.

Publication


Featured researches published by Theresa R. Fletcher.


Bioorganic & Medicinal Chemistry Letters | 2010

Orally Bioavailable Dual MMP-1/MMP-14 Sparing, MMP-13 Selective Alpha-sulfone Hydroxamates

Stephen A. Kolodziej; Susan L. Hockerman; Terri L. Boehm; Jeffery N. Carroll; Gary A Decrescenzo; Joseph J. Mcdonald; Debbie A. Mischke; Grace E. Munie; Theresa R. Fletcher; Joseph G. Rico; Nathan W. Stehle; Craig Swearingen; Daniel P. Becker

A series of phenyl piperidine alpha-sulfone hydroxamate derivatives has been prepared utilizing a combination of solution-phase and resin-bound library technologies to afford compounds that are potent and highly selective for MMP-13, are dual-sparing of MMP-1 and MMP-14 (MT1-MMP) and exhibit oral bioavailability in rats.


Journal of Medicinal Chemistry | 2016

Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis

Peter G. Ruminski; Mark A. Massa; Joseph Walter Strohbach; Cathleen E. Hanau; Michelle A. Schmidt; Jeffrey A. Scholten; Theresa R. Fletcher; Bruce C. Hamper; Jeffery N. Carroll; Huey S. Shieh; Nicole Caspers; Brandon Collins; Margaret L. Grapperhaus; Katherine E. Palmquist; Joe T. Collins; John E. Baldus; Jeffrey Hitchcock; H. Peter Kleine; Michael David Rogers; Joseph J. Mcdonald; Grace E. Munie; Dean Messing; Silvia Portolan; Laurence O. Whiteley; Teresa Sunyer; Mark E. Schnute

Matrix metalloproteinase-13 (MMP-13) is a zinc-dependent protease responsible for the cleavage of type II collagen, the major structural protein of articular cartilage. Degradation of this cartilage matrix leads to the development of osteoarthritis. We previously have described highly potent and selective carboxylic acid containing MMP-13 inhibitors; however, nephrotoxicity in preclinical toxicology species precluded development. The accumulation of compound in the kidneys mediated by human organic anion transporter 3 (hOAT3) was hypothesized as a contributing factor for the finding. Herein we report our efforts to optimize the MMP-13 potency and pharmacokinetic properties of non-carboxylic acid leads resulting in the identification of compound 43a lacking the previously observed preclinical toxicology at comparable exposures.


Bioorganic & Medicinal Chemistry Letters | 2011

Structure-based parallel medicinal chemistry approach to improve metabolic stability of benzopyran COX-2 inhibitors.

Li Xing; Bruce C. Hamper; Theresa R. Fletcher; Jay M. Wendling; Jeffery S Carter; James K. Gierse; Subo Liao

Combination of the structure-based design and solid-phase parallel synthesis provided an integrated approach to rapidly develop the structure-activity relationship of benzopyran COX-2 inhibitors. Binding free energies predicted by free energy perturbation theory yielded good agreement with experimental results. New potent and selective lead compounds with improved metabolic properties were identified.


Journal of Medicinal Chemistry | 2005

Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 2).

Horng-Chih Huang; Samuel J. Tremont; Len F. Lee; Bradley T. Keller; Andrew J. Carpenter; Ching-Cheng Wang; Shyamal C. Banerjee; Scott R. Both; Theresa R. Fletcher; Danny J. Garland; Wei Huang; Claude Jones; Kevin J. Koeller; Steve A. Kolodziej; James C. B. Li; Robert E. Manning; Matthew W. Mahoney; Raymond E. Miller; Deborah A. Mischke; Nigam P. Rath; Emily J. Reinhard; Michael B. Tollefson; William F. Vernier; Grace M. Wagner; Steve R. Rapp; Judy Beaudry; Kevin C. Glenn; Karen Regina; Joe R. Schuh; Mark E. Smith


Bioorganic & Medicinal Chemistry Letters | 2010

Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.

Mark E. Schnute; Patrick Michael O'brien; Joe Nahra; Mark Morris; W. Howard Roark; Cathleen E. Hanau; Peter G. Ruminski; Jeffrey A. Scholten; Theresa R. Fletcher; Bruce C. Hamper; Jeffery N. Carroll; William Chester Patt; Huey Shieh; Brandon Collins; Alexander Pavlovsky; Katherine E. Palmquist; Karl W. Aston; Jeffrey Hitchcock; Michael D. Rogers; Joseph J. Mcdonald; Adam R. Johnson; Grace E. Munie; Arthur J. Wittwer; Chiu-Fai Man; Steven L. Settle; Olga V. Nemirovskiy; Lillian E. Vickery; Arun Agawal; Richard D. Dyer; Teresa Sunyer


Bioorganic & Medicinal Chemistry Letters | 2003

A novel class of apical sodium co-dependent bile acid transporter inhibitors: the 1,2-benzothiazepines.

Michael B. Tollefson; Stephen A. Kolodziej; Theresa R. Fletcher; William F. Vernier; Judith A. Beaudry; Bradley T. Keller; David B. Reitz


Archive | 2004

Substituted pyrazole urea compounds for the treatment of inflammation

He Huang; Michael A. Stealey; Gunnar J. Hanson; Patrick J. Lennon; Bruce C. Hamper; Jin Xie; David S. Oburn; Serge G. Wolfson; Theresa R. Fletcher; Richard F. Heier; Matthew T. Reding; Michael Clare


Archive | 2005

Substituted thiophene amide compounds for the treatment of inflammation

Dominique Bonafoux; Michael Clare; Theresa R. Fletcher; Bruce C. Hamper; Patrick J. Lennon; William D. Mcghee; David S. Oburn; Matthew T. Reding; Michael B. Tollefson; Serge G. Wolfson


Archive | 2004

Benzopyran compounds for use in the treatment and prevention of inflammation related conditions

Jeffery S Carter; David L. Brown; Li Xing; Karl Aston; John Robert Springer; Francis J. Koszyk; Steven W. Kramer; Sofya Tsymbalov; Renee M. Huff; Yi Yu; Bruce C. Hamper; Subo Laio; Angela Michelle Deprow; Theresa R. Fletcher; E Hallinan; James R. Kiefer; David Limburg; Lijuan Wang


Archive | 2010

Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions

Mark E. Schnute; Jeffery N. Carroll; Cathleen E. Hanau; Matthew David Mcreynolds; Jeffrey A. Scholten; Joseph J. Mcdonald; Margaret L. Grapperhaus; Mark A. Massa; Peter G. Ruminski; Michelle A. Schmidt; Joseph Walter Strohbach; Bruce C. Hamper; Theresa R. Fletcher; Michael David Rogers; Patrick Michael O'brien; Joe Nahra; Mark Anthony Morris; William Howard Roark

Collaboration


Dive into the Theresa R. Fletcher's collaboration.

Researchain Logo
Decentralizing Knowledge